Search for: "SANDOZ, INC." Results 321 - 340 of 679
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Feb 2008, 2:55 pm
Sold in the United States under the brand name Duragesic by PriCara and generically by Sandoz Inc., the recall includes all 25-microgram-per-hour patches with expiration dates on or before December 2009. [read post]
27 Jul 2010, 4:55 am by FDABlog HPM
(“Sanofi”) sued FDA over the Agency’s July 23, 2010 approval of Sandoz Inc. [read post]
26 Jun 2007, 3:27 am
According to the Houston Chronicle, Texas is suing three drug companies alleging the companies took advantage of the Medicare system and cost the state tens of millions of dollars in overpayments.The lawsuit was filed against Sandoz, Inc. of New Jersey, Mylan Laboratories of Pennsylvania and Teva Pharmaceuticals, Inc., along with some of their subsidiaries. [read post]
7 Oct 2009, 9:59 pm
Sanofi originally filed suit against Sun, Sandoz, Actavis Inc., and Par Pharmaceutical Inc., among other generic manufacturers, in June 2007, accusing them of infringing Sanofi's patent covering Eloxatin ®, U.S. [read post]
13 Jul 2018, 5:54 pm by Lawrence B. Ebert
Sandoz, Inc., 678 F.3d 1280,1291 (Fed. [read post]
22 Nov 2019, 2:56 pm by Lawrence B. Ebert
Sandoz, Inc., 135 S.Ct. 831, 841 (2015).Of issue preclusionA leading treatise states that, as a general rule, “preclusion applies to any issue framed by the pleadings andnot withdrawn, even though it has not been raised at trialin any way. [read post]
5 Feb 2024, 4:00 am by Administrator
… The CourtAppeal Watch: the legality of multi-Crown class proceedings in Sandoz Canada Inc. v British Columbia Last November, the Supreme Court of Canada (“SCC”) granted leave to Sanis Health Inc., Shoppers Drug Mart Inc., Sandoz Canada Inc. and McKesson Canada Corporation to appeal Sandoz Canada Inc. v British Columbia, 2023 BCCA 306 (“Sandoz Canada”). [read post]
21 Sep 2018, 4:47 am by Dennis Crouch
Sandoz, Inc., et al., No. 18-21 (whether the court may “ignore a factual stipulation” resulting in a non-infringement finding). [read post]
7 Feb 2012, 2:25 pm by FDABlog HPM
District Court for the District of Columbia issued her decision in the long-running dispute concerning FDA’s July 23, 2010 approval of Sandoz Inc. [read post]